NVTA: Invitae Corporation - Summary | Jitta

Invitae Corporation

NYSE:NVTA

Price
$2.44
Loss Chance
56.7%
1.97JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
365 / 1,198
2,959 / 5,126
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (44)
Recent Business Performance (51)
Financial Strength (42)
Return to Shareholders (0)
Competitive Advantage (44)
Jitta Signs
Revenue and EarningEarning loss detected in 2021
Operating MarginInconsistent
Recent Business PerformanceEarning decline 20.26% in the last year
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.97
100.00%
2.06
143.77%
Health Care Services
6.42
58.60%
4.42
66.77%
8.00
17.72%
COMPANY DESCRIPTION
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.